Business Description
Founded in Copenhagen in 1998, Genmab is a Danish biotech company focused on developing antibody-based treatments for cancer and other serious illnesses. Its portfolio includes approved therapies for blood cancers, cervical cancer, multiple myeloma, thyroid eye disease, and multiple sclerosis, with a broad pipeline targeting additional conditions such as lung cancer, ovarian cancer, sickle cell disease, and hemophilia. The company works alongside a number of major pharmaceutical partners, including Johnson & Johnson, Pfizer, AbbVie, Amgen, and Bristol Myers Squibb.
